BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21152652)

  • 21. A pickup in pseudokinase activity.
    Dar AC
    Biochem Soc Trans; 2013 Aug; 41(4):987-94. PubMed ID: 23863168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for activation of the titin kinase domain during myofibrillogenesis.
    Mayans O; van der Ven PF; Wilm M; Mues A; Young P; Fürst DO; Wilmanns M; Gautel M
    Nature; 1998 Oct; 395(6705):863-9. PubMed ID: 9804419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC; Kraft AS
    Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon gamma bound to endothelial cells is phosphorylated by ecto-protein kinases.
    Al-Nedawi KN; Pawłowska Z; Cierniewski CS
    Acta Biochim Pol; 1999; 46(3):693-702. PubMed ID: 10698277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical probes of signal-transducing proteins.
    Lawrence DS
    Acc Chem Res; 2003 Jun; 36(6):401-9. PubMed ID: 12809526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzymatically modified peptide surfaces: towards general electrochemical sensor platform for protein kinase catalyzed phosphorylations.
    Martić S; Labib M; Kraatz HB
    Analyst; 2011 Jan; 136(1):107-12. PubMed ID: 21042631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation.
    Romaker D; Schregel V; Maurer K; Auerochs S; Marzi A; Sticht H; Marschall M
    J Med Chem; 2006 Nov; 49(24):7044-53. PubMed ID: 17125257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the catalytic mechanism of the p21-activated protein kinase PAK2.
    Wu H; Zheng Y; Wang ZX
    Biochemistry; 2003 Feb; 42(4):1129-39. PubMed ID: 12549935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase structure and function analysis with chemical tools.
    Shen K; Hines AC; Schwarzer D; Pickin KA; Cole PA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):65-78. PubMed ID: 16213197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the roles of protein kinases using chemical genetics.
    Elphick LM; Lee SE; Anderson AA; Child ES; Bonnac L; Gouverneur V; Mann DJ
    Future Med Chem; 2009 Oct; 1(7):1233-41. PubMed ID: 21426100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDX-MS takes centre stage at unravelling kinase dynamics.
    Lorenzen K; Pawson T
    Biochem Soc Trans; 2014 Feb; 42(1):145-50. PubMed ID: 24450642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Versatile strategy for biochemical, electrochemical and immunoarray detection of protein phosphorylations.
    Martić S; Gabriel M; Turowec JP; Litchfield DW; Kraatz HB
    J Am Chem Soc; 2012 Oct; 134(41):17036-45. PubMed ID: 22764889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The resistance tetrad: amino acid hotspots for kinome-wide exploitation of drug-resistant protein kinase alleles.
    Bailey FP; Andreev VI; Eyers PA
    Methods Enzymol; 2014; 548():117-46. PubMed ID: 25399644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discovery.
    Sawyer TK; Shakespeare WC; Wang Y; Sundaramoorthi R; Huang WS; Metcalf CA; Thomas M; Lawrence BM; Rozamus L; Noehre J; Zhu X; Narula S; Bohacek RS; Weigele M; Dalgarno DC
    Med Chem; 2005 May; 1(3):293-319. PubMed ID: 16787325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate specificity of protein kinases and computational prediction of substrates.
    Kobe B; Kampmann T; Forwood JK; Listwan P; Brinkworth RI
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):200-9. PubMed ID: 16172032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revisiting protein kinase-substrate interactions: Toward therapeutic development.
    de Oliveira PS; Ferraz FA; Pena DA; Pramio DT; Morais FA; Schechtman D
    Sci Signal; 2016 Mar; 9(420):re3. PubMed ID: 27016527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting protein kinases with selective and semipromiscuous covalent inhibitors.
    Miller RM; Taunton J
    Methods Enzymol; 2014; 548():93-116. PubMed ID: 25399643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational diversity of catalytic cores of protein kinases.
    Sowadski JM; Epstein LF; Lankiewicz L; Karlsson R
    Pharmacol Ther; 1999; 82(2-3):157-64. PubMed ID: 10454194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The structural basis for control of eukaryotic protein kinases.
    Endicott JA; Noble ME; Johnson LN
    Annu Rev Biochem; 2012; 81():587-613. PubMed ID: 22482904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using chemical genetics and ATP analogues to dissect protein kinase function.
    Elphick LM; Lee SE; Gouverneur V; Mann DJ
    ACS Chem Biol; 2007 May; 2(5):299-314. PubMed ID: 17518431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.